FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and aims at preventing, treating or managing cancer, preferentially metastatic cancer, in a patient. The method involves administering an effective amount of Axl inhibitor in a combination with an effective amount of one or more chemotherapeutic substance. The Axl inhibitor represents 1-(6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-(7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)-1H-1,2,4-triazole-3,5-diamine in the form of a recovered stereoisomer or a mixture thereof, or in the form of a tautomer or a mixture thereof, or their pharmaceutically acceptable salt or N-oxide. The chemotherapeutic substance is specified in a group consisting of: cisplatin, lapatinib, erlotinib, gemcitabine, doxorubicine, paclitaxel, cytarabine and docetaxel.
EFFECT: method enables increasing the clinical effectiveness in cancer, reducing side effects.
5 cl, 11 ex, 16 dwg
| Title |
Year |
Author |
Number |
| BICYCLIC PYRIDINE DERIVATIVES USEFUL AS FATTY ACID BINDING PROTEIN (FABP) 4 AND / OR 5 INHIBITOR |
2013 |
- Byuttelmann Bernd
- Konte Aureliya
- Kyune Kholger
- Kun Bernd
- Najdkhart Verner
- Obst Zander Ulrike
- Rikhter Khans
|
RU2648247C2 |
| METHOD OF RESIDUAL LIPOPROTEINS PRODUCING INHIBITION |
2004 |
- Okamoto Khirosi
- Furukava Noboru
- Sasase Tomokhiko
|
RU2330682C2 |
| BICYCLIC LACTAMS AND METHODS OF USE THEREOF |
2016 |
- Patel, Snakhel
- Gamilton, Gregori
- Stivala, Krejg
- Chen, Khuejfen
- Chzhao, Gujlin
|
RU2827714C1 |
| MALONAMIDE DERIVATIVES AS γ-SECRETASE INHIBITORS |
2004 |
- Gallej Guido
- Gergle Annik
- Jakobzen Khel'Mut
- Kitas Ehrik Argirios
- Peters Jens-Uve
|
RU2330849C2 |
| NEW BICYCLIC COMPOUNDS OF THIOPHENYLAMIDE |
2013 |
- Byuttelmann Bernd
- Chekkarelli Simona M.
- Kyune Kholger
- Kun Bernd
- Najdkhart Verner
- Obst Zander Ulrike
- Rikhter Khans
|
RU2644565C2 |
| SELECTIVE HISTAMINE H4 RECEPTOR ANTAGONISTS FOR TREATING VESTIBULAR DISORDERS |
2009 |
- Desmadril Zhil
- Shaber Kristyan
|
RU2589846C2 |
| PYRIDAZINE DERIVATIVES |
2006 |
- Amrajn Kurt
- Khuntsiker Daniel'
- Kun Bernd
- Majveg Aleksander F.
- Najdkhardt Verner
|
RU2401832C2 |
| DERIVATIVES OF 5-(AMINO-SUBSTITUTED)-1,2,4-TRIAZOLO-[1,5-A]-PYRIMIDINE, THEIR PHARMACEUTICALLY ACCEPTABLE ACID-ADDITIVE SALTS, PHARMACEUTICAL COMPOSITION SHOWING CARDIOTONIC AND CORONARY-DILATING ACTION AND A METHOD OF CARDIOTONIC AND/OR CORONARY-DILATING EFFECT ON HEART |
1992 |
- Jozhef Rejter[Hu]
- Gabor Berezh[Hu]
- Giella Zhila[Hu]
- Lujza Petech[Hu]
- Gabor Gigler[Hu]
- Marton Fekete[Hu]
- Maria Sechej[Hu]
- Ehnike Sirt[Hu]
- Ludmila Rokhach[Hu]
- Fridesh Gergejni[Hu]
- Margit Cherge[Hu]
|
RU2097382C1 |
| COMPOSITION FOR KERATIC FIBRE COLOURING CONTAINING AT LEAST ONE DIAMINO-N, N-DIHYDROPYRAZOLONE DERIVATIVE |
2004 |
|
RU2330909C2 |
| DERIVATIVES OF 7-PHENOXY-N-(3-AZABICYCLO[3.2.1]OCTAN-8-YL)-6,7-DIHYDRO-5H-PYRROLO[1,2-b][1,2,4]TRIAZOLE-2-AMINE AND RELATED COMPOUNDS AS GAMMA-SECRETASE MODULATORS FOR TREATING ALZHEIMER'S DISEASE |
2019 |
|
RU2841048C2 |
